Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.56 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | ACE | P12821 | 7/20 | 0.55 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.55 |
| ▸ | MME | P08473 | 6/20 | 0.52 |
| ▸ | CPA1 | P15085 | 1/20 | 0.51 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | ALB | P02768 | 1/20 | 0.46 |
| ▸ | IL2 | P60568 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1008925 | 1.00 | FOLH1 (0.56) | FOLH1NAALAD2MEN1KMT2AL3MBTL1 | |
| SCHEMBL22290826 | 0.85 | ALDH1A1 (0.57) | FOLH1KMT2AACEMMECPA1 | |
| SCHEMBL29964738 | 0.85 | ALDH1A1 (0.57) | FOLH1KMT2AACEMMECPA1 | |
| SCHEMBL144008 | 0.85 | MME (0.57) | FOLH1NAALAD2L3MBTL1ACESLC7A5 | |
| SCHEMBL199980 | 0.85 | MME (0.57) | FOLH1NAALAD2L3MBTL1ACESLC7A5 | |
| SCHEMBL31345792 | 0.85 | MME (0.57) | FOLH1NAALAD2L3MBTL1ACESLC7A5 | |
| SCHEMBL144009 | 0.85 | MME (0.57) | FOLH1NAALAD2L3MBTL1ACESLC7A5 | |
| SCHEMBL22290975 | 0.84 | FPR2 (0.54) | FOLH1NAALAD2MEN1KMT2AL3MBTL1 | |
| SCHEMBL22290683 | 0.84 | ADAMTS5 (0.54) | KMT2ACA2 | |
| SCHEMBL22290939 | 0.84 | FPR2 (0.54) | MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117337295-A | Bicyclic peptide ligands specific for TREM2 | 拜斯科技术开发有限公司 | 2024-01-02 | — | — | CN | claimed |
| EP-3558395-A1 | TUMOR AND IMMUNE CELL IMAGING BASED ON PD-L1 EXPRESSION | The Johns Hopkins University (US) | 2019-10-30 | — | — | EP | claimed |
| CN-110366432-A | Tumour and immunocyte imaging based on PD-L1 expression | 约翰霍普金斯大学 | 2019-10-22 | — | — | CN | claimed |
| US-20190314531-A1 | TUMOR AND IMMUNE CELL IMAGING BASED ON PD-L1 EXPRESSION | THE JOHNS HOPKINS UNIVERSITY | 2019-10-17 | — | — | US | claimed |
| CN-109295025-A | The protein photo induced electron transfer fluorescent optical sensor protein family of Tyrosine Analogues translation system and gene coding | 中国科学院生物物理研究所 | 2019-02-01 | — | — | CN | claimed |
| WO-2018119313-A1 | TUMOR AND IMMUNE CELL IMAGING BASED ON PD-L1 EXPRESSION | THE JOHNS HOPKINS UNIVERSITY (US) | 2018-06-28 | — | — | WO | claimed |
| CN-102516003-A | Methods for the purification of radiolabelled products using a solid-support scavenger | HAMMERSMITH IMANET LTD | 2012-06-27 | — | — | CN | claimed |
| CN-102333536-A | Ss-arrestin effectors and compositions and methods of use thereof | TREVENA INC | 2012-01-25 | — | — | CN | claimed |
| CN-102132280-A | Model enhanced imaging | KONINKL PHILIPS ELECTRONICS NV | 2011-07-20 | — | — | CN | claimed |
| EP-2032711-A1 | HOST CELLS AND USES THEREOF IN THE MICROBIAL PRODUCTION OF HYDROXYLATED AROMATICS | Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO (NL) | 2009-03-11 | — | — | EP | claimed |
| WO-2007133084-A1 | HOST CELLS AND USES THEREOF IN THE MICROBIAL PRODUCTION OF HYDROXYLATED AROMATICS | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) | 2007-11-22 | — | — | WO | claimed |
| US-20050214776-A1 | Aequorin and obelin mutants with differing wavelengths and bioluminescence | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2005-09-29 | — | — | US | claimed |
| JP-3188002-A | — | — | None | — | — | JP | disclosed |
| US-12637494-B2 | Method for producing peptide containing non-natural amino acid | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2026-05-26 | — | — | US | disclosed |
| EP-4713675-A1 | ELECTROCHEMICAL METHOD AND SENSOR FOR PFAS DETECTION | B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University (IL) | 2026-03-25 | — | — | EP | disclosed |
| US-20250340916-A1 | METHOD FOR SYNTHESIZING PEPTIDES IN CELL-FREE TRANSLATION SYSTEM | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2025-11-06 | — | — | US | disclosed |
| WO-1995033843-A1 | DEBLOCKING THE COMMON PATHWAY OF AROMATIC AMINO ACID SYNTHESIS | PURDUE RESEARCH FOUNDATION (US) | 1995-12-14 | — | — | WO | disclosed |
| WO-1995014710-A1 | CHEMICALLY MODIFIED BINDING PROTEIN | YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) | 1995-06-01 | — | — | WO | disclosed |
| JP-H03188002-A | PRESERVATIVE FOR CUT FLOWER | SUMITOMO CHEM CO LTD | 1991-08-16 | — | — | JP | disclosed |
| US-4925651-A | TUMOR DIAGNOSIS | KERNFORSCHUNGSANLAGE JUELICH GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1990-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637494-B2 | Method for producing peptide containing non-natural amino acid | MRPL21, RPL21, RPL30 | FOLH1 2856/4885NAALAD2 1127/4885MEN1 3529/4885 |
| US-20190314531-A1 | TUMOR AND IMMUNE CELL IMAGING BASED ON PD-L1 EXPRESSION | CD274, PDCD1LG2, PDCD1 | FOLH1 276/4885NAALAD2 2292/4885MEN1 673/4885 |
| US-20250340916-A1 | METHOD FOR SYNTHESIZING PEPTIDES IN CELL-FREE TRANSLATION SYSTEM | AARS1, NSUN3, RNGTT | FOLH1 1210/4885NAALAD2 835/4885MEN1 2488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.